Cardiovascular and Renovascular Implications of COX-2 Inhibition

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|6|603-611

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.6, 2004-02, pp. : 603-611

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Implications of COX-1 and / or COX-2 Inhibition for the Distal Gastrointestinal Tract

By  

Current Pharmaceutical Design, Vol. 9, Iss. 27, 2003-10 ,pp. : 2253-2266

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the field of COX-2 inhibition

By Delarge Jacques   Dogné Jean-Michel   Julémont Fabien   Leval Xavier de   Pirotte Bernard   Sanna Vanna  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 7, 2002-07 ,pp. : 969-989

Informa Healthcare

Access to resources Recommend Favorite

Mucosal Repair and COX-2 Inhibition

By  

Current Pharmaceutical Design, Vol. 9, Iss. 27, 2003-10 ,pp. : 2207-2211

Bentham Science Publishers

Access to resources Recommend Favorite

Structural Approach for COX-2 Inhibition

By  

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 6, 2004-08 ,pp. : 603-615

Bentham Science Publishers

Access to resources Recommend Favorite

Preface [Hot topic: Implications of COX-2 Inhibition in the Gastrointestinal Tract (Executive Editor : Angel Lanas)]

By  

Current Pharmaceutical Design, Vol. 9, Iss. 27, 2003-10 ,pp. : i-ii

Bentham Science Publishers

Access to resources Recommend Favorite